Bevacizumab is contraindicated in patients with known hypersensitivity to: Any components of the product; Chinese hamster ovary cell products or other recombinant human or humanized antibodies.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
